Unity Biotechnology Inc

-0.02 (-2.84%)
Earnings Announcements

Unity Biotechnology Reports Q1 2022 Results

Published: 05/10/2022 20:59 GMT
Unity Biotechnology Inc (UBX) - Unity Biotechnology, Inc. Reports First Quarter 2022 Financial Results and Business Updates.
Believes That Current Cash, Cash Equivalents, and Marketable Securities Are Sufficient to Fund Operations Through Q1 of 2023.
Qtrly Net Loss per Share, Basic and Diluted $0.28.
Q1 Earnings per Share View $-0.26 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.